Budesonide Suspension
Product Images NDC 62135-823

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 62135-823). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Budesonide Inhalation Suspension 0pt25mg 2ml Carton Label)

Budesonide 0.25 mg/2 mL inhalation suspension carton label for respiratory use. The package is for 30 sterile unit-dose ampules, labeled for prescription use only. Manufactured by Chartwell RX, LLC, the label includes dosage strength and directions for storage and handling.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension 0pt5mg 2ml Carton Label)

Carton label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Chartwell RX, LLC. The label states it is for inhalation use only and Rx only. Packaging includes 30 x 2 mL plastic sterile unit-dose ampules in pouch sets of 6 ampules. The design includes dosing and storage instructions along with the lot number and barcode visible.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension Graph 1)

A line graph depicting mean change from baseline in negative asthma symptoms over a 12-week period. The x-axis represents time intervals from baseline to weeks 0-12, while the y-axis shows mean symptom change values. Four treatment groups are charted: placebo, 0.25 mg once daily, 0.5 mg once daily, and 1.0 mg once daily, each represented by different markers. Statistical p-values for each dosage versus placebo are noted at the bottom.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension Graph 2)

A line graph showing mean change from baseline in nighttime asthma symptoms over a 12-week period. The graph compares placebo, 0.25 mg twice daily, and 0.5 mg twice daily doses of Budesonide inhalation suspension, with data points marked at intervals from baseline to week 12.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension Graph 3)

A line graph depicting the mean change from baseline in nighttime asthma symptoms over a 12-week period for various doses of Budesonide inhalation suspension, including placebo, 0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily. The x-axis represents time in weeks, and the y-axis represents the change in symptom scores, showing trends of improvement for different dosing regimens.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension Picture 1)

An instructional illustration showing a hand holding several small single-dose ampules of Budesonide respiratory suspension, demonstrating how to handle or prepare the inhalation suspension for administration.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension Picture 1a)

An instructional illustration showing a hand holding a medication dispenser or inhaler device with the cap being removed or attached. This figure likely demonstrates part of the steps for preparing or using the inhalation suspension device.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension Picture 2)

Instructional illustration labeled Figure 2 showing a hand holding a respiratory inhalation device, demonstrating a twisting or turning motion with the thumb and fingers, likely part of the preparation or activation of the Budesonide inhalation suspension device.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension Picture 3)

An instructional illustration showing a person holding and preparing an inhalation suspension device, specifically a budesonide respiratory inhalation suspension syringe or vial, with one hand on the device and the other hand adjusting or holding it.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension Picture 4)

An instructional illustration showing a person holding a small container or inhaler in one hand while adding liquid from a vial or ampule held in the other hand above it. The image appears to demonstrate a step in preparing or loading the respiratory inhalation suspension Budesonide.*

FDA Label Image

Image Description (Budesonide Inhalation Suspension Structure)

Chemical structure of Budesonide, shown as a detailed molecular diagram with labeled carbon, hydrogen, and oxygen atoms. The structure depicts the steroid backbone and additional functional groups relevant to Budesonide's molecular composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.